EMA — authorised 9 December 2022
- Marketing authorisation holder: MIRUM PHARMACEUTICALS INTERNATIONAL B.V.
- Status: approved
🇪🇺 Livmarli in European Union
EMA authorised Livmarli on 9 December 2022
Marketing authorisation
Livmarli in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in European Union
Frequently asked questions
Is Livmarli approved in European Union?
Yes. EMA authorised it on 9 December 2022.
Who is the marketing authorisation holder for Livmarli in European Union?
MIRUM PHARMACEUTICALS INTERNATIONAL B.V. holds the EU marketing authorisation.